Radiation Dose Management Market Worth $749.1 Million by 2029 - Exclusive Report by Meticulous Research®

Radiation Dose Management Market by Solution & Service, Modality (CT, Nuclear Medicine, Fluoroscopy, Mammography), Application (Oncology, Cardiology, Orthopedic, Neurology), End User (Hospitals, Ambulatory Care Setting) - Global Forecast to 2029


Redding, California, Dec. 06, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, Radiation Dose Management Market by Solution & Service, Modality (CT, Nuclear Medicine, Fluoroscopy, Mammography), Application (Oncology, Cardiology, Orthopedic, Neurology), End User (Hospitals, Ambulatory Care Setting) - Global Forecast to 2029,’ published by Meticulous Research®, the radiation dose management market is projected to reach $749.1 million by 2029, at a CAGR of 13.3% from 2022 to 2029.

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5394
Radiation dose management has increased due to increased availability and reliance on high-dose imaging modalities for rapid and comprehensive diagnosis and treatment. However, medical imaging procedures pose risks due to high doses of radiation to patients. To tackle this, major players are launching radiation dose management products. For instance, in November 2021, Siemens Healthineers (Germany) launched NAEOTOM Alpha, the world’s first CT scanner with photon-counting technology. This system increases resolution and reduces radiation dose by up to 45 percent for ultra-high resolution (UHR) scans compared with conventional CT detectors. This reduction in radiation dose enables regular examinations such as lung cancer screenings using CT imaging on a routine basis for a large patient population.

The demand for radiation dose management is experiencing a surge owing to the increasing use of diagnostic imaging modalities, concerns regarding radiation exposure, and increasing awareness about radiation dose management.

Impact of COVID-19 on the Radiation Dose Management Market

Using imaging equipment on COVID-19 patients posed a serious hazard for other patients and healthcare providers. Thus, many countries postponed non-urgent diagnostic imaging surgeries, which reduced the reliance on medical imaging. Additionally, during the pandemic, the U.S. Centers for Disease Control and Prevention and the American College of Radiology did not recommend the routine use of chest radiographs or CT scans alone to diagnose COVID-19. Furthermore, the American College of Radiology issued guidance that CTs and x-rays should not be used as a first-line tool to diagnose or screen for COVID-19. This temporarily impacted the market negatively.

The radiation dose management market is segmented by Offering (Solutions, Services), Modality (Computed Tomography, Fluoroscopy & Interventional Imaging, Nuclear Medicine, Radiography & Mammography), Application (Oncology, Cardiology, Orthopedics, Neurology, Other Applications), End User (Ambulatory Care Settings, Hospitals, Other End Users). The study also evaluates industry competitors and analyzes their market shares at the regional and country levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5394

Based on offering, in 2022, the solutions segment is expected to account for the largest share of the market. The increase in the use of medical imaging owing to the rise in the prevalence of chronic diseases and the presence of regulations for exposure to ionizing radiation are the factors contributing to the largest share of the market.

Based on modality, in 2022, the computed tomography segment is expected to account for the largest share of the market. Increased computed tomography examinations and a surge in the awareness of radiation dose exposure are contributing to the large market share of this segment.

Based on application, in 2022, the oncology segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing burden of cancer and increased usage of imaging modalities in oncology.

Based on end user, in 2022, the hospitals segment is expected to account for the largest share of the market. A high patient population, a surge in chronic diseases, awareness about early diagnosis, the preference for non-invasive medical procedures, and technological advancements in imaging modalities are contributing to the large market share of this segment.

Quick Buy – Radiation Dose Management Market- Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/86897349

Based on geography, in 2022, North America is expected to account for the largest share of the radiation dose management market. The large share of this market is attributed to factors such as advanced healthcare infrastructure, technological advancements, high awareness related to radiation exposure, and strict accreditation & regulatory requirements related to radiation exposure. According to American Cancer Society Recommendations for the Early Detection of Cancer, women between the age of 40-54 should undergo regular screening mammography starting at age 45. Additionally, U.S. healthcare expenditure increased from USD 2,658 Billion in 2009 to USD 3,795 Billion in 2019. These factors have contributed significantly to the large market share of the region.

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past years (2020–2022). In the last couple of years, the global radiation dose management market has witnessed strategic developments such as product launches and enhancements.

Some of the key players operating in the global radiation dose management market are Bayer AG (Germany), Siemens Healthineers GmbH (Germany), Bracco Imaging S.p.A. (Italy), FUJIFILM Holdings Corporation (Japan), GE Healthcare (U.S.), Medsquare (France), Novarad Corporation (U.S.), PACSHealth, LLC. (U.S.), Koninklijke Philips N.V. (Netherlands), Qaelum N.V. (Belgium), Sectra AB (Sweden), Agfa Healthcare (Belgium), Canon Inc. (Japan), Guerbet (France), Medic Vision (U.S.), and Volpara Health Limited (U.S.).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/radiation-dose-management-market-5394

Scope of the Report:

Radiation Dose Management Market, by Offering

  • Solutions
  • Services

Radiation Dose Management Market, by Modality

  • Computed Tomography
  • Fluoroscopy and Interventional Imaging
  • Nuclear Medicine
  • Radiography and Mammography

Radiation Dose Management Market, by Application

  • Oncology
  • Cardiology
  • Orthopedics
  • Neurology
  • Other Applications

Note: Other applications include dermatology and ophthalmology

Radiation Dose Management Market, by End User

  • Ambulatory Care Settings
  • Hospitals
  • Other End Users

Note: Other end users include diagnostic centers, research institutions, and academic centers.

Radiation Dose Management Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5394
Related Reports:

X-ray Detectors Market by Product Type (FPD, CSI, GADOX, CR, CCD), FOV (Large, Medium, Small), Portability (Portable, Fix), System (New, Retrofit), And Application [Medical (Mammogram, Spine), Dental, Security, Industrial, Veterinary] - Global Forecast to 2029

https://www.meticulousresearch.com/product/x-ray-detectors-market-4555

Breast Imaging Market by Technology [Ionizing (FFDM, Analog, 3D Mammogram, CT, CBCT), Non-Ionizing (Breast Ultrasound, Breast MRI, AWBU, Breast Thermography)], End User (Hospital, Diagnostic Imaging Center), and Geography - Forecast to 2027

https://www.meticulousresearch.com/product/breast-imaging-market-4959

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) - Global Forecast to 2029

https://www.meticulousresearch.com/product/artificial-intelligence-in-medical-diagnostics-market-5312

Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecasts to 2025

https://www.meticulousresearch.com/product/radiotherapy-market-5023

Diagnostic Imaging Market by Product (X-ray (Digital, Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear Imaging (SPECT, PET), Application (Orthopedic, OB/GYN, MSK, Cardiology, Oncology), End User (Hospital, Imaging Centers) - Global Forecast to 2025

https://www.meticulousresearch.com/product/diagnostic-imaging-market-4950

X-ray Inspection Systems Market for Electronics & Semiconductors by Component (Hardware, Software, Services, Consumables), Imaging Technique (Film-based Imaging, Digital Imaging), Dimension (2D X-ray, 3D X-ray), Application, and Geography - Global Forecast to 2029

https://www.meticulousresearch.com/product/x-ray-inspection-systems-market-for-electronics-and-Semiconductors-5253

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/622/radiation-dose-management-market-2029

 

Contact Data